de Kort Sander, Bouwens Mariëlle We, Weijenberg Matty P, Janssen-Heijnen Maryska Lg, de Bruïne Adriaan P, Riedl Robert, Masclee Ad Am, Sanduleanu Silvia
Division of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.
Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
United European Gastroenterol J. 2017 Apr;5(3):415-423. doi: 10.1177/2050640616664271. Epub 2016 Aug 9.
Diabetes mellitus (DM) is associated with a greater risk for colorectal cancer (CRC).
The objective of this article is to examine the endoscopic phenotype and histopathology of colorectal polyps in patients with vs without DM.
We conducted a cross-sectional study of patients who underwent colonoscopy at our university hospital and who completed a questionnaire. We collected endoscopy and histopathology data regarding colorectal adenomas and serrated polyps. Cox regression analyses were used to estimate adjusted prevalence ratios (PRs).
We examined a total of 3654 patients (mean age (SD): 62 (12) years, 47% males). Of them, 360 (9.9%) had DM. Overall, the prevalence of colorectal adenomas (42% vs 32%, < 0.01), multiple (≥3) adenomas (12% vs 7%, = 0.01) and proximal adenomas (30% vs 19%, < 0.01) was higher in patients with vs without DM. Multivariable analysis showed that the prevalence of adenomas (PR 1.17, 95% CI; 1.02-1.34), multiple (PR 1.37, 95% CI; 1.00-1.86) and proximal (PR 1.37, 95% CI; 1.16-1.62) adenomas was higher in patients with vs without DM, especially in men.
Patients with DM harbor more frequently multiple and proximal adenomas than those without DM. Close colonoscopic surveillance of DM patients is important to maximize the effectiveness of colonoscopic CRC prevention.
糖尿病(DM)与结直肠癌(CRC)风险增加相关。
本文旨在研究糖尿病患者与非糖尿病患者结直肠息肉的内镜表型和组织病理学。
我们对在我校医院接受结肠镜检查并完成问卷的患者进行了一项横断面研究。我们收集了有关结直肠腺瘤和锯齿状息肉的内镜及组织病理学数据。采用Cox回归分析来估计调整后的患病率比(PRs)。
我们共检查了3654例患者(平均年龄(标准差):62(12)岁,47%为男性)。其中,360例(9.9%)患有糖尿病。总体而言,糖尿病患者结直肠腺瘤的患病率(42%对32%,<0.01)、多发(≥3个)腺瘤的患病率(12%对7%,=0.01)和近端腺瘤的患病率(30%对19%,<0.01)高于非糖尿病患者。多变量分析显示,糖尿病患者腺瘤的患病率(PR 1.17,95%置信区间;1.02 - 1.34)、多发腺瘤的患病率(PR 1.37,95%置信区间;1.00 - 1.86)和近端腺瘤的患病率(PR 1.37,95%置信区间;1.16 - 1.62)高于非糖尿病患者,尤其是男性。
糖尿病患者比非糖尿病患者更常发生多发和近端腺瘤。对糖尿病患者进行密切的结肠镜监测对于最大限度提高结肠镜预防结直肠癌的有效性很重要。